We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTG.RT
7276
DELISTED
Reaves Utility Income Fund
UTG.RT
$10K ﹤0.01%
+27,316
New +$5.54K
LODE icon
7277
Comstock
LODE
$252M
$9K ﹤0.01%
+239
New +$10.7K
BINI
7278
DELISTED
Bollinger Innovations
BINI
0
BIMI
7279
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$9K ﹤0.01%
203
-105
-34% -$4.49K
BONT
7280
CALL
DELISTED
Bon-Ton Stores Inc/The
BONT
$9K ﹤0.01%
20,000
+4,700
+31% +$2.72K
CRDF icon
7281
Cardiff Oncology
CRDF
$77.3M
$8K ﹤0.01%
+148
New +$9.23K
TMBR
7282
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$8K ﹤0.01%
2
+1
+100% +$5.14K
SNMX
7283
DELISTED
Senomyx, Inc.
SNMX
$8K ﹤0.01%
12,912
-13,288
-51% -$9.21K
CYTR
7284
CALL
DELISTED
CytRx Corp
CYTR
$8K ﹤0.01%
3,383
-2,367
-41% -$8K
NUWE icon
7285
Nuwellis
NUWE
$477K
0
PHIO icon
7286
Phio Pharmaceuticals
PHIO
$12.9M
-1
Closed -$34.5K
ADYX
7287
DELISTED
Adynxx Inc
ADYX
$7K ﹤0.01%
312
-588
-65% -$12.2K
RPRX
7288
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$7K ﹤0.01%
20,800
-16,400
-44% -$5.75K
SLS icon
7289
PUT
SELLAS Life Sciences
SLS
$2.49B
$6K ﹤0.01%
12
+3
+33% +$1.98K
AMPE
7290
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
33
-94
-74% -$14.9K
CNSY
7291
CALL
Cerenome, Inc. Common Stock
CNSY
$24.6M
0
CEI
7292
DELISTED
Camber Energy, Inc
CEI
0
NSPR icon
7293
InspireMD
NSPR
$40.3M
0
AAXJ icon
7294
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
-26,267
Closed -$1.77M
ABG icon
7295
CALL
Asbury Automotive
ABG
$3.79B
-3,800
Closed -$215K
ABUS icon
7296
Arbutus Biopharma
ABUS
$904M
-14,428
Closed -$52K
ACLS icon
7297
CALL
Axcelis
ACLS
$4.38B
-10,100
Closed -$212K
ACM icon
7298
Aecom
ACM
$8.14B
-71,237
Closed -$2.34M
ACM icon
7299
PUT
Aecom
ACM
$8.14B
-11,300
Closed -$365K
ACN icon
7300
Accenture
ACN
$107B
-35,957
Closed -$4.68M

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.